Zhejiang Aoxiang Pharmaceutical Co., Ltd., headquartered in Taizhou City, Zhejiang Province, was established in 2010 and listed on the Shanghai Stock Exchange in May 2017. We currently have over 1000 employees and multiple subsidiaries both domestically and internationally. The company is planning to establish research and development centers in cities such as Shanghai, Hangzhou, Changsha, and Chengdu. The company is mainly engaged in the research and development, production, and sales of specialty active pharmaceutical ingredients, key intermediates, and pharmaceutical formulations, as well as providing CDMO services to customers. The products are mainly exported to countries and regions such as Europe, the United States, Japan, and South Korea. The company is a national high-tech enterprise and has established platforms such as a national postdoctoral workstation, Zhejiang Province Key Enterprise Research Institute for High end Chiral Drugs, and Zhejiang Province Enterprise Technology Center. At present, the company is actively building a research and development center in Hangzhou. At the end of 2022, Zhejiang Qizheng Pharmaceutical Co., Ltd., a subsidiary of the formulation company located in the main urban area of Taizhou, has started production.

Zhejiang Aoxiang Pharmaceutical Co., Ltd. launches the 2024 Safety Production Month Fire Skills Competition. A total of 87 colleagues competed on the same stage, forming teams to compete in three person three roll and air breathing wearable competition subjects. The company's production management personnel and EHS management personnel jointly participated in the exhibition competition

In order to firmly establish the concept of safe development, enhance safety awareness, build a solid defense line for safety production, and implement the idea of safety production, from June 17 to June 20, Aoxiang Pharmaceutical organized the "Everyone Talks about Safety, Everyone Knows Emergency Response - Smooth Life Channel" Safety Production Month Knowledge Competition.